At a glance
ClinicalIndex Comparison Record- ✓Age 18 years or older
- ✓Pathologically confirmed head and neck cancer (larynx, pharynx, oral cavity, paranasal sinuses, major salivary glands, or unknown primary)
- ✓Completed curative-intent cancer therapy with no evidence of active cancer at enrollment
- ✓Diagnosis of internal or external head and neck lymphedema
- ✕Previous treatment with advanced pneumatic compression device or usual care for head and neck lymphedema
- ✕Acute facial infection (facial or parotid gland abscess)
- ✕Known carotid sinus hypersensitivity syndrome
- ✕Symptomatic carotid artery disease: recent TIA, ischemic stroke, or amaurosis fugax within 30 days
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of an Advanced Pneumatic Compression Device vs. Usual Care for Head and Neck Lymphedema
In Brief
A clinical study evaluating Advanced Pneumatic Compression Device (APCD) and Usual Care for Lymphedema and 4 related conditions. Completed, enrolled 236 participants across 10 sites.
Detailed Summary
To compare the effectiveness of an APCD to Usual Care in the management of lymphedema and fibrosis (LEF) in head and neck cancer (HNC) survivors.
Study Details
Timeline
Interventions
Once daily treatment with Flexitouch Plus.
Usual care consists of a two-phase CDT. Phase 1 includes consultation with a lymphedema therapist, patient education, MLD, compression garments or bandages, skin care techniques, and a program of exercises and postural recommendations. Phase 2 consists of ongoing self-care, where patients conduct a life-long program of disease management that mimics the program in phase 1.